Amgen Execs to Present at Jefferies Healthcare Conference
Event summary
- Amgen will present at the Jefferies Global Healthcare Conference on June 4, 2026, at 9:55 a.m. ET.
- Executives presenting include Peter Griffith (CFO), Narimon Honarpour (Global Development), and Kave Niksefat (Global Marketing and Access).
- The webcast will be available live and archived for at least 90 days on Amgen's website.
The big picture
Amgen's participation in the Jefferies Global Healthcare Conference underscores its commitment to transparency and strategic communication with investors. As a key player in the biotechnology sector, Amgen's updates on its pipeline and financial performance will be closely watched, especially given its inclusion in the Dow Jones Industrial Average and Nasdaq-100 Index. The conference provides a platform for Amgen to reinforce its market position and address any concerns related to its broad portfolio of medicines.
What we're watching
- Pipeline Updates
- How Amgen's presentation will highlight progress in its pipeline for cancer, inflammatory conditions, rare diseases, heart disease, and obesity-related conditions.
- Market Positioning
- Whether Amgen can sustain its leadership in the biotechnology sector amid increasing competition.
- Financial Performance
- The pace at which Amgen's financial strategies will be communicated and their potential impact on investor sentiment.
Related topics